TP53 and neoplasm: Reprimo (RPRM), TP53 dependent G2 arrest mediator candidate, is a highly glycosylated protein and initially discovered as a putative tumor-suppressor involved in the regulation of p53-dependent G2 arrest of the cell cycle [4, 5].